Records containing: ITP
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-20A Multicenter, Randomized, Double-blinded, Parallel-Arm, Placebo-Controlled, Pharmacokinetic and Pharmacodynamic Study Followed by an Open-Label Arm to Evaluate Efgartigimod IV in Pediatric Participants From 12 Years to Less Than 18 Years of Age With Chronic ITP
-
CLINICAL_TRIALS study record update · 2026-03-27A Phase 1b/2a, Open-Label, Sequential-Cohort, Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Clinical Effectiveness of Budoprutug (TNT119) in Subjects With Immune Thrombocytopenia (ITP)
-
CLINICAL_TRIALS study record update · 2025-10-09Safety and Efficacy of Romiplostim in Treatment of Chronic ITP in Children
-
CLINICAL_TRIALS study record update · 2025-07-14An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® (Avatrombopag) in Adult Patients With Immune Thrombocytopenia (ITP)
-
CLINICAL_TRIALS study record update · 2024-05-07A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-04-09Daratumumab as a Treatment for Adult Immune Thrombocytopenia (The DART Study)
-
CLINICAL_TRIALS study record update · 2024-03-15Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy (FORTE)
-
CLINICAL_TRIALS study record update · 2023-08-09IL37,Tlymphocytes ,NK Cells in Pathogenesis of Immune Thrombocytopenia.
-
CLINICAL_TRIALS study record update · 2022-09-28Efficacy and Safety of Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia: A Single-arm, Open-label Phase II Study
-
CLINICAL_TRIALS study record update · 2022-08-26IMMUNE THROMBOCYTOPENIA (ITP) AND COVID-19: National Retrospective and Prospective Observational Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP
-
CLINICAL_TRIALS study record update · 2022-05-02The Combination of Iguratimod and Danazol Versus Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia: A Randomized, Controlled, Multicenter, Open-label Trial
-
CLINICAL_TRIALS study record update · 2022-04-07Anti-BCMA CAR T-Cell Therapy for Relapsed/Refractory Immune Thrombocytopenia
-
CLINICAL_TRIALS study record update · 2022-02-08Personalized Machine-Learning Based Prediction Model for Bleeding in Immune Thrombocytopenia: a Nationwide Representative Data Study
-
CLINICAL_TRIALS study record update · 2022-01-12Diagnostic and Therapeutic Value of Gut Microbiome in Adult Immune Thrombocytopenia
-
CLINICAL_TRIALS study record update · 2021-02-10The Combination of High-dose Dexamethasone and Tacrolimus Versus High-dose Dexamethasone as the First-Line Treatment of Newly-diagnosed Immune Thrombocytopenia: A Randomized, Controlled, Multicenter, Open-label Trial
-
CLINICAL_TRIALS study record update · 2019-09-13Multicenter, Randomized, Open, Parallel Controlled Trials Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)
-
CLINICAL_TRIALS study record update · 2017-09-18Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With 3 Cycles Pulses of High-dose Dexamethasone (HD-DXM)